Phase 1/2 FLAG-IDA, VEN and Asciminib in CML and Ph+ AML
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Fludarabine
Related studies linked through entity extraction aliases.
Target-Selected CAR-NK Cells (CD30, CD5, or Mesothelin) for Relapsed/Refractory B2 Thymoma or Thymic Carcinoma
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Bendamustine Versus Fludarabine/Cyclophosphamide for Lymphodepletion in Chimeric Antigen Receptor T-cell Immunotherapy (CAR-T): a Randomized Trial.
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Adapt NK for High Risk Myeloid Diseases as Bridge to Allo HSCT
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Dual-Target CAR-NK Cells in Recurrent or Refractory Epithelial Ovarian Cancer
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Phase 1/2 Study of EB-NK-301 (Allogeneic TROP2-CAR NK Cells) in Advanced TROP2-Expressing Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
BSB-2002 After Cyclophosphamide and Fludarabine for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia Patients With NPM1 Mutation
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
CD30 CAR-T Cells for Low Risk Relapsed Classical Hodgkin Lymphoma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
A Safety and Tolerability Study of CC- 97540 (BMS-086353) in Anti-Aquaporin 4 Antibody Positive Neuromyelitis Optica Patients
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
Anti-CRLF2-R/TSLPR Chimeric Antigen Receptor T Cells (TSLPR-CART) in Participants With Recurrent or Refractory CRLF2-R/TSLPR-Overexpressing B-Cell Acute Lymphoblastic Leukemia (B-ALL)
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
Frontline Risk-Adapted Optimization of Novel Targeted Immunotherapy Evaluation in High-Risk MCL
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Cord Blood Transplantation in Children and Young Adults With Blood Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Thiotepa-based Conditioning Regimen With De-escalated Post-graft Cyclophosphamide for Allogeneic Stem Cell Transplantation in Hematologic Malignancies
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
Phase 1 Study Of LNK001 In Advanced Or Metastatic Clear Cell Renal Cell Carcinoma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
TBF Conditioning Regimen for Haploidentical Stem Cell Transplantation in Elderly AML Patients in First Complete Remission
- Status
- NOT_YET_RECRUITING
- Phase
- NA
Dual-target CLDN18.2/HER2 CAR-NK Cells for Advanced Gastric/GEJ Cancer
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Dual-target CD70/CAIX CAR-NK Cells for Advanced Clear Cell Renal Cell Carcinoma
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Dual-Targeting CAR-NK Cells for Recurrent/Progressive Glioblastoma and High-Grade Glioma
- Status
- RECRUITING
- Phase
- PHASE1
Safety and Pharmacodynamics of QH103 Cell Injection in the Treatment of Patients With Relapsed/Refractory Antibody-Mediated Neurological Autoimmune Diseases.
- Status
- RECRUITING
- Phase
- PHASE1
Stem Cell Transplantation for Participants With Germline RUNX1 Associated Blood Cancers
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2